blog contains data on market size, growth and/or competitor shares
A key driving force in the market for wound management is the reduction of costs associated with managing chronic wounds. Central to this is clinical challenge of dealing with pressure ulcers. Below is an excerpt on pressure ulcers from the MedMarket Diligence report #S247, "Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets [...]
Medtech financings year to date (through August 2010) now stand at $2.57 billion, about 17% ahead of financings by this date in 2009. August 2010 financing came in at a modest $267 million, following the year-high month of July which had financings of $518 million. If the remainder of 2010 follows a typical course, total [...]
It is illustrative to put the individual components of the global diabetes market into context. Below is illustrated the global diabetes market segmented by geography, with further detail shown for the U.S. markets product segments. The U.S. represents the single largest share of the global diabetes market, with insulin, glucose meter test strips (not including [...]
Type 1 diabetes is still treated with insulin injections. Insulin is supplied in a variety of long, intermediate and short-acting preparations. The duration of action of insulin preparations required to give optimal control varies from patient to patient. This means that individual patients are established on particular regimens which are not changed unless they are [...]
The European market for ablation technologies shows considerable variation by modality and country, given the differences in adoption rates for the different modalities, the local practice patterns and other regional variations. Below is illustrated the distribution of the ablation market by modality across the major markets in Western Europe. Source: MedMarket DIligence, LLC; Report #A145, [...]
The market for tissue engineering and cell therapy products is set to grow to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall [...]
The U.S. market for products in the management of diabetes represents roughly 38% of a $41 billion global annual market. Products in the market are currently comprised of blood glucose monitors, lancets and test strips, continuous blood glucose monitors, insulin, insulin pumps, syringes and other insulin delivery devices and anti-diabetic drugs. The most significant growth [...]
Ablation technologies are a growth medtech field driven as much by physicians pursuing larger caseload as manufacturers developing innovative technologies, according to a new global report from MedMarket Diligence. (PressMethod) – Surgical procedures focus on a wide range of clinical endpoints — the creation of a lesion to block aberrant cardiac rhythms, the destruction of [...]
(See PRLog press release at link.) As well established as the practices are for the management of types 1 and 2 diabetes, a raft of new technologies, from modest to radical, are steadily entering clinical practice and the industry, according to a new report from MedMarket Diligence. FOR IMMEDIATE RELEASE PRLog (Press Release) – Aug [...]
Much attention has been paid to the development of cell therapies with cardiovascular applications. According to the Institute of Cardiovascular Regeneration, more than 1,500 patients with cardiovascular diseases are treated with adult progenitor cells worldwide. Much success has been achieved in this sector and cardiovascular cell therapies are increasingly becoming viable technologies. The primary competitors [...]
Contact:
